ethica CRO


The ethica CRO
Difference
Management

Janice E. Parente, PhD
President

Janice completed both her PhD and Post-Doctoral Fellowship in Molecular Pharmacology, and proceeded to develop her skills at the Director level within global pharma before founding her first contract research organization (CRO) in 1992. During the ensuing decade, Janice established her credentials as a successful and respected business leader and entrepreneur. In 2002, she sold her company in order to found ethica Clinical Research Inc., instilling in it her values and commitment to the protection of human research participants. This commitment led to ethica becoming the first Canadian entity and the first CRO in the world to earn full accreditation of its Human Research Protection Program (HRPP) in 2006.

Janice's leadership and entrepreneurship have been recognized through numerous awards and nominations such as the prestigious Ernst & Young and Bank of Montreal Entrepreneur of the Year Awards and PROFIT Magazine's PROFIT W100 ranking of Canada's Top Women Entrepreneurs.

Murray L., Jensen, MSc
Managing Director

As Managing Director, Murray is responsible for ethica CRO's business operations and plays a key role in the clinical and scientific affairs of the company. Murray completed his MSc in Medical Science (Neuropathology) before embarking on a successful career in drug development with companies in the global pharmaceutical, biotechnology and CRO industries. Over the course of more than 20 years in drug research, he has led the development of pharmaceutical and diagnostic products in a variety of therapeutic areas. Over the years, ethica CRO's clients have benefited greatly from Murray's creativity and unsurpassed knowledge of drug development.

ethica Request a proposal

ethica Investigator Manual